Neurobehavioral mechanisms of fear and anxiety in multiple sclerosis.

Journal: Communications medicine
Published Date:

Abstract

BACKGROUND: Anxiety is a common yet often underdiagnosed and undertreated comorbidity in multiple sclerosis (MS). While altered fear processing is a hallmark of anxiety in other populations, its neurobehavioral mechanisms in MS remain poorly understood. This study investigates the extent to which neurobehavioral mechanisms of fear generalization contribute to anxiety in MS.

Authors

  • Lil Meyer-Arndt
    Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Rebekka Rust
    Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité-University Hospital Berlin, 10117, Berlin, Germany.
  • Judith Bellmann-Strobl
    Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), NeuroCure Clinical Research Center, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universitt zu Berlin, Berlin Institute of Health (BIH), Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, 10117 Berlin, Germany.
  • Tanja Schmitz-Hübsch
    Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine, Charité-University Hospital Berlin, 10117, Berlin, Germany.
  • Lajos Marko
    Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Sofia Forslund
    Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Michael Scheel
    Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Department of Neurology, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), NeuroCure Clinical Research Center, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universitt zu Berlin, Berlin Institute of Health (BIH), Department of Neuroradiology, 10117 Berlin, Germany.
  • Stefan M Gold
    Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Stefan Hetzer
  • Friedemann Paul
    Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Department of Neurology, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), NeuroCure Clinical Research Center, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universitt zu Berlin, Berlin Institute of Health (BIH), Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, 10117 Berlin, Germany; Einstein Center for Digital Future Berlin, Germany.
  • Martin Weygandt
    Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Department of Neurology, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), NeuroCure Clinical Research Center, 10117 Berlin, Germany.

Keywords

No keywords available for this article.